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Abstract. 
 
Previous studies have indicated that newly 
formed oligodendrocytes are dynamic cells whose pro-
duction, survival, and differentiation depend upon ax-
onal influences. This study has characterized the ap-
pearance and fate of newly formed oligodendrocytes in 
developing rat brain. Oligodendrocytes appear in pre-
dictable locations and radially extend DM-20–positive 
processes that cover 80-
 
m
 
m domains in the cortex and 
40-
 
m
 
m domains in the corpus callosum. These premy-
elinating oligodendrocytes have one of two fates: they 
myelinate axons or degenerate. Between 7 and 21 d af-
 
ter birth, 
 
z
 
20% of premyelinating oligodendrocytes 
identified in the cerebral cortex were degenerating. Oli-
godendrocytes that ensheathed axons expressed and se-
lectively targeted proteolipid protein to compact mye-
lin and did not degenerate. These observations support 
the hypothesis that axonal influences affect oligoden-
drocyte survival, differentiation, and expression of pro-
teolipid protein gene products.
 
O
 
ligodendrocytes
 
, the myelin-forming cell in the
central nervous system (CNS)
 
1
 
, are neuroepithe-
lial in origin. In vitro studies have identified and
characterized a progenitor cell, termed O2A, which gives
rise to oligodendrocytes in serum-free medium or to astro-
cytes in serum-containing medium (Raff et al., 1983). Cells
committed to the oligodendrocyte lineage in vitro can re-
spond to a variety of growth factors, and based on morphol-
ogy and molecular phenotype, they are generally grouped
into progenitors, immature oligodendrocytes (premyelinat-
ing), and mature oligodendrocytes (myelinating) (Gard
and Pfeiffer, 1990; Hardy and Reynolds, 1991; Dubois-
Dalcq and Armstrong, 1992; Miller, 1996). PDGF binds to
and stimulates the division of O2A cells in vitro (Richard-
son et al., 1988; Hart et al., 1989
 
b
 
), and as O2A cells differ-
entiate into oligodendrocytes, they downregulate PDGF
 
a
 
R
and fail to bind or respond to PDGF (Hart et al., 1989
 
a
 
).
The proteoglycan, NG2, colocalizes with PDGF
 
a
 
R in vitro
and in vivo (Nishiyama et al., 1996
 
a
 
), and these molecules
may be functionally coupled on the surface of O2A cells
(Nishiyama et al., 1996
 
b
 
). PDGF
 
a
 
R-/NG2-positive cells
populate the brain well before myelination begins (Nish-
iyama et al., 1996
 
a
 
), and dual-labeling studies indicate that
these cells can give rise to galactocerebroside- and myelin
basic protein (MBP)-positive oligodendrocytes (Levine et
al., 1993; Nishiyama et al., 1996
 
a
 
).
Studies using retroviral markers (Levison and Goldman,
1993) and immunocytochemical studies using glycolipid
and ganglioside antibodies (LeVine and Goldman, 1988;
Gard and Pfeiffer, 1990; Hardy and Reynolds, 1991; War-
rington and Pfeiffer, 1992) have identified immature or
premyelinating oligodendrocytes in developing rodent brain.
Myelin protein antibodies have not been used to identify
premyelinating oligodendrocytes in vivo. mRNA encoding
DM-20, a spliced product of the proteolipid protein (PLP)
gene, has been detected in developing brain before myelin
formation (Macklin, 1992; Timsit et al., 1995), and mice with
PLP gene mutations have phenotypes at stages before ac-
tive myelin formation (Skoff, 1982; Knapp et al., 1986).
These observations suggest that DM-20 is expressed by
immature or premyelinating oligodendrocytes.
In vitro studies have established that oligodendrocytes
are dynamic cells that can respond to a variety of external
influences. Critical to our understanding of oligodendro-
cyte lineage in vivo is the characterization of factors that
regulate their numbers and survival. Recent studies of op-
tic nerve have established that axonal signals regulate oli-
godendrocyte production and survival (Barres and Raff,
1993, 1994; Barres et al., 1993; Burne et al., 1996) and that
as many as 50% of all newly formed oligodendrocytes die
by programmed cell death (Barres et al., 1992). Similar to
many developing neurons, newly formed oligodendrocytes
appear to compete for survival factors, and their overpro-
duction presumably helps assure that all appropriate ax-
ons are myelinated. While our understanding of oligoden-
drocyte lineage in vivo is evolving, further characterization
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Abbreviations used in this paper
 
: CNS, central nervous system; MAG,
myelin-associated glycoprotein; MBP, myelin basic protein; PLP, proteo-
lipid protein.
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of the appearance, fate, and molecular events that occur
during oligodendrocyte differentiation is needed. There-
fore, we used antibodies directed against the myelin pro-
teins PLP and DM-20 to characterize oligodendrocyte lin-
eage in vivo. Our results demonstrate that DM-20–positive
premyelinating oligodendrocytes are produced in predict-
able locations during development and suggest that their
survival is dependent on myelination of appropriate axons.
In addition, we provide evidence that as oligodendrocytes
ensheath axons, they express and selectively target PLP to
developing myelin internodes.
 
Materials and Methods
 
Immunocytochemical Analysis
 
3-, 7-, 11- 14-, 21-, and 28-d-old and adult Sprague Dawley rats were anes-
thetized and perfused through the heart with 4% paraformaldehyde and
0.08 M Sorensen’s phosphate buffer. The brains were removed, postfixed
overnight at 4
 
8
 
C, and cryoprotected in 20% glycerol. Brains were frozen
and sectioned on a freezing, sliding microtome (Microm, Heidelberg, Ger-
many) at a thickness of 30 
 
m
 
m. Sections were rinsed in buffer and pre-
treated with microwave (1 to 2 min), 10% Triton X-100, and 1% H
 
2
 
O
 
2
 
 (30
min). Sections were stained by the avidin/biotin complex procedure by
placing the sections in the following solutions: 3% normal serum for 30
min at 22
 
8
 
C, primary antibodies for 5 d at 4
 
8
 
C, biotinylated secondary an-
tibodies (Vector Laboratories, Burlingame, CA) diluted 1:500 for 30 min
at 22
 
8
 
C, enzyme (HRP)-linked biotin diluted 1:1,000, and avidin diluted
1:1,000 (Vector Laboratories) in PBS for 1 h, diaminobenzidine/hydrogen
peroxide for 8 min, and 0.04% osmium tetroxide for 30 s. After the immu-
nostaining procedure, the sections were rinsed in buffer, placed on glass
slides, and covered with 100% glycerol and coverslips. Sections were pho-
tographed with a photomicroscope (model Axiophot; Carl Zeiss, Inc.,
Thornwood, NY).
For double-labeling immunofluorescence and confocal studies, sections
were pretreated as described above and incubated in two primary anti-
bodies for 5 d at 4
 
8
 
C. Fluorescence- and Texas red–conjugated secondary
antibodies (diluted 1:100) (Jackson Laboratories, West Grove, PA) were
applied for 1 h. Sections were rinsed and mounted in a Mowiol-based
(Calbiochem, San Diego, CA) mounting medium containing 0.1% para-
phenylene-diamine hydrochloride. For combined nuclear chromatin and
DM-20/PLP staining, 30-
 
m
 
m-thick sections were immunostained by the
avidin/biotin complex procedures as described above, rinsed in buffer, and
placed in Hoechst 3325A dye (8 
 
m
 
g/ml in PBS) (Sigma Chemical Co., St.
Louis, MO) for 60 min. Sections were rinsed, placed on slides, and cov-
ered with glycerol and coverslips. Immunoreactivity was photographed
with bright-field optics. Hoechst 3325A staining was photographed under
ultraviolet illumination.
 
Antibodies
 
Rat monoclonal antibodies directed against the 13 carboxy-terminal
amino acids of DM-20 and PLP were purchased from Agmed Inc. (Bed-
ford, MA). Rabbit polyclonal antibodies were generated against the 35
amino acids specific for PLP protein. Western blot analysis confirmed the
specificity of the reactivity of these two reagents. Rabbit anti–rat NG2 an-
tibody was kindly provided by Joel Levine (State University of New York
at Stony Brook) and has been described (Levine et al., 1993).
 
Confocal Microscopy
 
Sections were analyzed on a confocal laser scanning microscope (model
Aristoplan; Leica, Inc., Deerfield, IL). Confocal images represent optical
sections of 
 
z
 
1 
 
m
 
m axial resolution. Single images represented an average
of 32 line scans of the chosen field. Fluorescence in red and green chan-
nels was collected simultaneously. In the red/green merged images, areas
of colocalization are yellow. Images were photographed with a focus
graphics 35-mm film recorder.
 
Morphometric and Statistical Analysis
 
The diameter or area occupied by DM-20/PLP–positive premyelinating
oligodendrocytes was measured using a microscope (model Axiophot;
Carl Zeiss, Inc.) fitted with a grid-patterned reticule and a 40
 
3
 
 objective.
In the corpus callosum, the cells were measured perpendicular to the cell
cluster and developing axons. Measurements were converted to microns
and unpaired Student’s 
 
t
 
 test was used for comparing the diameter of cells
in the cortex and corpus callosum.
 
Results
 
Characterization of Premyelinating Oligodendrocytes in 
the Cerebral Cortex and Corpus Callosum
 
To determine if premyelinating oligodendrocytes could be
identified with DM-20/PLP antibodies, sections of devel-
oping rat brain were immunostained with a monoclonal
antibody directed against the 13 carboxy-terminal amino
acids common to both proteins. In the cerebral cortex, my-
elination occurs in a predictable temporal and spatial se-
quence during the first three postnatal weeks. Myelination
begins rostral to corpus callosum and progresses to the
pial surface. Fig. 1 
 
A
 
 demonstrates the distribution of DM-
20/PLP immunoreactivity in 11-d-old rat brain. Vertically
oriented DM-20/PLP–positive, myelinated fibers extend
from the deep cortical layers toward the pial surface.
Patches of DM-20/PLP staining were also present near the
leading edge of the myelination front (Fig. 1 
 
A
 
, 
 
arrow-
heads
 
) and in layer I of the cortex. Most brain regions con-
taining patches of DM-20/PLP immunoreactivity at 11 d are
myelinated by 21 d (Fig. 1 
 
B
 
). When examined at higher
magnification, many of these patches consisted of single
cells that symmetrically radiated DM-20/PLP–positive
processes (Fig. 1 
 
C
 
, 
 
arrowheads
 
). Occasionally, these cells
occurred in pairs (Fig. 1 
 
C
 
, 
 
asterisk
 
), and processes of these
paired cells occupied separate neuropil domains. Other
DM-20/PLP–positive cells were connected to developing
myelin internodes (Fig 1 
 
C
 
, 
 
arrows
 
) and were located in
deeper layers of the cortex. Some areas of DM-20/PLP im-
munoreactivity were fragmented and covered neuropil ar-
eas that were similar in size to oligodendrocytes that radi-
ally extend multiple processes (Fig. 1 
 
D
 
, 
 
arrowheads
 
).
These profiles represent dying oligodendrocytes, and they
are described in detail below.
Premyelinating oligodendrocytes detected in the devel-
oping corpus callosum were strikingly different from those
in the cerebral cortex. DM-20/PLP–positive cell bodies
usually occurred in clusters of two to four cells (Fig. 2, 
 
A
 
and 
 
B
 
, 
 
arrowheads
 
) that were oriented parallel to develop-
ing axons. These cells extended multiple processes that ap-
peared to overlap extensively. At postnatal day 7, some
clusters of DM-20/PLP–positive cells did not include obvi-
ous developing myelin internodes (Fig. 2 
 
A
 
; also see Fig. 3,
 
C
 
 and 
 
D
 
), while others did (Fig. 2 
 
B
 
, 
 
arrows
 
). By postnatal
day 11, the corpus callosum contained many clusters of
DM-20/PLP–positive cells and developing myelin internodes
(Fig. 2 
 
C
 
). Since our analysis suggested that premyelinat-
ing oligodendrocytes in the cerebral cortex had more orderly
arranged processes than those in the corpus callosum, sec-
tions stained with DM-20/PLP antibodies were analyzed
by confocal microscopy (Fig. 3). Fig. 3 
 
A
 
 is a single confo-
cal image (
 
z
 
1.0-
 
m
 
m-thick) of a premyelinating oligoden-
drocyte in the developing cerebral cortex. Fig. 3 
 
B
 
 is a stack
of 20 confocal images (
 
z
 
20-
 
m
 
m-thick) of the same cell.
The relatively symmetrical and nonoverlapping distribu- 
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tion of the DM-20/PLP–positive processes is apparent in
both images. When a similar comparison was performed
on a cluster of premyelinating oligodendrocytes in the de-
veloping corpus callosum (Fig. 3, 
 
C
 
 and 
 
D
 
), their processes
arborized and overlapped extensively. Our initial immu-
nocytochemical analysis also suggested that premyelinat-
ing oligodendrocytes occupied larger neuropil domains in
the cerebral cortex than in the corpus callosum. Therefore,
Figure 1. Comparison of the distribution of DM-20/PLP immunoreactivity in sections from 11- (A) and 21-d-old (B) rat brain. The in-
creased distribution of immunoreactivity in B reflects the developmental progression of myelination. Premyelinating oligodendrocytes
are concentrated at the leading edge of myelinated fibers projecting toward the pial surface (A, arrowheads) and in layer I of the cortex.
Premyelinating oligodendrocytes radially extend multiple processes that cover distinct neuropil domains (C, arrowheads). While most
premyelinating oligodendrocytes in the cerebral cortex are separated from each other, occasional pairs are detected (C, asterisk). Pro-
cesses of adjacent cells rarely overlap even when cells appear in pairs. Myelinating oligodendrocytes (C, arrows) send processes to verti-
cally oriented DM-20/PLP–positive myelin internodes. Other regions of DM-20/PLP immunoreactivity is fragmented (D, arrowheads)
and covers approximately the same neuropil area as healthy-appearing premyelinating oligodendrocytes (D, arrow). Bars: (A and B)
200 mm; (C and D) 50 mm. 
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the radius of the area occupied by cell bodies and pro-
cesses of individual DM-20/PLP–positive premyelinating
oligodendrocytes in P7 corpus callosum and cerebral cor-
tex was compared. The radius of premyelinating cells was
78.5 
 
6
 
 8.2 
 
m
 
m (
 
n
 
 
 
5
 
 60) in the cortex and 39.8 
 
6
 
 9.5 
 
m
 
m (
 
n
 
5
 
 45) in the corpus callosum. Student’s 
 
t
 
 test demon-
strated that this difference was statistically significant (
 
P
 
 
 
,
 
0.001).
 
Premyelinating Oligodendrocytes Differentiate into 
Myelinating Oligodendrocytes
 
The distribution of DM-20/PLP immunoreactivity indi-
cated that premyelinating oligodendrocytes differentiate
into myelinating oligodendrocytes in predictable locations
in the cerebral cortex. Fig. 4 depicts three stages in the
progression from premyelinating to myelin-forming oligo-
dendrocyte. The premyelinating oligodendrocyte in Fig. 4 
 
A
 
radially extends DM-20/PLP–positive processes that have
no obvious extensions along axons. Initial stages of myeli-
nation can be identified by the extension of T-shaped pro-
cesses from the premyelinating oligodendrocytes (Fig. 4 
 
B
 
,
 
arrowheads
 
). The top of the T’s are oriented parallel to ax-
onal bundles and represent initial stages of axonal en-
sheathment. Analysis of cells in more advanced stages of
myelination (Fig. 4 
 
C
 
) indicated that only a small percent-
age of the premyelinating oligodendrocyte processes en-
sheath axons. Fragmented DM-20/PLP–positive processes
were not detected near developing myelin internodes, sug-
gesting that premyelinating oligodendrocyte processes that
do not ensheath axons were resorbed.
The proteolipid protein gene produces two alternatively
spliced proteins (DM-20 and PLP) that differ by 35 addi-
tional amino acids (exon 3b) in PLP. Previous studies have
indicated that DM-20 is expressed before PLP during
brain development (Macklin, 1992; Timsit et al., 1995). To
determine if DM-20 and PLP could be detected at differ-
ent stages of oligodendrocyte differentiation, sections
were double-labeled with one antibody specific for DM-
20/PLP and another specific for PLP. Premyelinating and
myelinating oligodendrocytes were identified and exam-
ined by confocal microscopy. The PLP-specific antibody
did not stain premyelinating oligodendrocytes. During
early stages of myelin formation (cells extending multiple
DM-20/PLP–positive processes and short DM-20/PLP–
positive developing myelin internodes), PLP was detected
in oligodendrocyte perinuclear cytoplasm and in some of
the developing internodes (Fig. 5 
 
A
 
). At later stages of
myelination (Fig. 5 
 
B
 
), all developing myelin internodes
were both DM-20/PLP and PLP positive. These observa-
tions indicate that PLP is expressed at very low levels in
premyelinating oligodendrocytes and during early stages
of axonal ensheathment and that PLP is targeted exclu-
sively to myelin internodes. In contrast, DM-20 was de-
tected on all surface membranes of premyelinating and
myelinating oligodendrocytes. These observations raise
the possibility that axonal influences regulate differential
expression of PLP gene products as premyelinating oligo-
dendrocytes differentiate into myelinating oligodendro-
cytes.
 
Degeneration of Premyelinating Oligodendrocytes
 
A proportion of DM-20/PLP–positive cells, located in the
same brain regions as the premyelinating oligodendro-
cytes described above, had fragmented DM-20/PLP immu-
noreactivity. Many such cells retained the shape and size
of premyelinating oligodendrocytes, while other regions of
DM-20/PLP immunoreactivity consisted of dots that were
less orderly but distributed over an 80-
 
m
 
m radius. Cells
with fragmented DM-20/PLP immunoreactivity appear to
represent premyelinating oligodendrocytes that are de-
generating, which is consistent with previous studies dem-
onstrating extensive programmed cell death during early
Figure 2. Premyelinating oligodendrocytes in the corpus callosum from 7- (A and B) and 11-d-old (C) rats. DM-20/PLP–positive premy-
elinating oligodendrocytes occur in clusters (A and B, arrowheads) in the corpus callosum. Clustered perikarya appear before evidence
of myelin formation (A) and persist during active myelination (B and C). Bars, 50 mm.Trapp et al. Oligodendrocyte Lineage In Vitro 463
stages of oligodendrocyte differentiation (Barres et al.,
1992). A salient morphological feature of cells undergoing
programmed cell death is fragmentation and condensation
of nuclear chromatin. To determine if premyelinating oli-
godendrocytes with fragmented PLP/DM-20 staining also
contained fragmented nuclear chromatin, sections were
stained with DM-20/PLP antibodies and with a DNA-
binding dye. Premyelinating oligodendrocytes with evenly
distributed DM-20/PLP staining had diffuse and evenly
stained nuclear chromatin (Fig. 6 A), while cells with frag-
mented DM-20/PLP staining had fragmented and con-
densed nuclear chromatin (Fig. 6, B and C). At the leading
edge of myelination in the cerebral cortex, the total num-
ber of premyelinating cells was greatest at postnatal days
11 and 14 (Table I), reflecting peak periods of initial stages
of myelination. The percentage of total premyelinating
cells that were degenerating was z20% between postnatal
days 7 and 21 and was 37% at day 28 (Table I).
Origin of Premyelinating Oligodendrocytes
To investigate if DM-20/PLP–positive cells originate from
NG2-positive cells or from another cell that is committed
to the oligodendrocyte lineage, sections were double-labeled
with NG2 and DM-20/PLP antibodies and examined by
confocal microscopy. In sections from 3-d-old brain, NG2-
positive cells were present throughout the cerebral cortex,
but few DM-20/PLP-positive cells were detected (data not
shown). Sections from 7-d-old brain contained significant
numbers of DM-20/PLP–positive premyelinating oligo-
dendrocytes (Fig. 7). While most cells were stained with
either NG2 or DM-20/PLP antibodies (Fig. 7 A), a small but
consistent population of cells was stained by both antibod-
ies (Fig. 7, B and C). Cells positive for both NG2 and
DM-20/PLP were identified by weak DM-20/PLP immu-
noreactivity in perinuclear cytoplasm and on proximal
processes. When both channels were imaged, the intensity
of NG2 and DM-20/PLP immunoreactivity in double-labeled
Figure 3. Premyelinating oligodendrocytes in cerebral cortex and corpus callosum have different morphologies. Confocal images of sin-
gle (A and C) and reconstructions of 20 (B and D) 1-mm-thick optical sections of DM-20/PLP–positive premyelinating oligodendrocytes
from the cerebral cortex (A and B) and corpus callosum (C and D). Cortical cells (A and B) extend an orderly array of processes that
tend to branch in a Y-shaped manner as they terminate. Premyelinating oligodendrocytes in the corpus callosum (C and D) occur in
groups and extend processes in a less orderly and overlapping fashion. Bars, 10 mm.The Journal of Cell Biology, Volume 137, 1997 464
cells was much weaker than that detected in surrounding
cells, which were either NG2 or DM-20/PLP positive.
These observations provide additional support that NG2-
positive progenitor cells produce oligodendrocytes in vivo
(Levine et al., 1993; Nishiyama et al., 1996a).
Discussion
Based on the distribution of PLP and DM-20, this study
provides additional insights into the molecular and cellular
events that occur during oligodendrocyte differentiation in
vivo. Our studies confirm that a significant percentage of
newly formed oligodendrocytes degenerate and provide
the first description of their location and phenotype. Oli-
godendrocytes that degenerate express DM-20 and do not
ensheath axons or express detectable levels of PLP, the
major structural protein of compact myelin. These obser-
vations are consistent with the hypothesis that oligoden-
Figure 4. Premyelinating oligodendrocytes differentiate into myelinating oligodendrocytes. DM-20/PLP–positive oligodendrocytes
before myelination (A), during early stages of axonal ensheathment (B, arrowheads), and during active myelination (C). Bar, 10 mm.
Figure 5. Comparison of the distribution of DM-20/PLP (red) and PLP (green) in confocal images of oligodendrocytes. Areas of colo-
calization appear yellow. During early stages of axonal ensheathment, DM-20/PLP immunoreactivity is evenly distributed on oligoden-
drocyte processes (A, red) and developing myelin internodes (A, red and yellow), while PLP-specific immunoreactivity is restricted to
perinuclear cytoplasm and developing myelin internodes (A, yellow). In more mature oligodendrocytes, DM-20/PLP is detected in oli-
godendrocyte processes and myelin, while PLP is restricted to perinuclear cytoplasm and myelin (B, yellow). Asterisks and arrowheads
denote nucleus of cell and myelin internodes. Bars, 10 mm.Trapp et al. Oligodendrocyte Lineage In Vitro 465
drocyte cell death occurs before any significant commit-
ment to myelin formation and that axonal ensheathment is
essential for oligodendrocyte survival. Fig. 8 schematically
summarizes stages and features of oligodendrocyte differ-
entiation in vivo and is based on differential detection of
DM-20 and PLP in confocal images. This model supports
and extends those proposed previously (Hardy and Rey-
nolds, 1991; Warrington and Pfeiffer, 1992; Ffrench-Con-
stant, 1992; Barres and Raff, 1994) and is based on direct
analysis of cells in vivo.
Oligodendrocyte Progenitors
PDGFaR-, NG2-positive cells originate from discrete re-
gions of the ventricular zone of the diencephalon (Hart et al.,
1989a; Pringle et al., 1992; Pringle and Richardson, 1993;
Nishiyama et al., 1996a). They migrate, proliferate, and
form a network of process-bearing cells that populate the
cortex before birth (Nishiyama et al., 1996a). Each cell es-
tablishes a microdomain within the neuropil, and contact
inhibition with neighboring NG2 cells may, in part, control
their distribution. The location of cells immunostained by
both NG2 and DM-20 antibodies (Fig. 7) provides addi-
tional evidence that NG2-positive cells give rise to oligo-
dendrocytes (Levine et al., 1993; Nishiyama et al., 1996a).
Our studies indicate that DM-20 immunoreactivity is a re-
liable marker for newly formed oligodendrocytes, and the
detection of the occasional NG2/DM-20–positive cells makes
it unlikely that stages of oligodendrocyte lineage exist be-
tween NG2- and DM-20–positive cells. NG2-positive cells,
however, may represent a heterogeneous population of
cells with regard to stage and commitment to oligodendro-
cyte lineage, and they could have functions unrelated to
oligodendrocyte progenitors. The rate of oligodendrocyte
lineage cell differentiation can differ significantly in vari-
ous brain regions. In the hindbrain, oligodendrocytes are
produced 2–3 d after the appearance of PDGFaR mRNA–
positive cells (Hardy and Friedrich, 1996), whereas a simi-
lar transition can take several weeks in the cerebral cortex.
In addition, a distinct stage of oligodendrocyte progenitors
(041/R-mAb2) has been described in vitro (Hardy and
Reynolds, 1991; Bansal et al., 1992; Gard and Pfeiffer,
1993) and in perinatal forebrain (Pfeiffer et al., 1993) but
was not detected in hindbrain (Hardy and Friedrich, 1996).
Developmental and regional variations in axonal matura-
tion and in the timing of progenitor cell generation and mi-
gration throughout the CNS may be responsible for these
differences.
Differentiation of Myelinating Oligodendrocytes
Fig. 4 presents a logical progression in the differentiation
of a premyelinating to a myelinating oligodendrocyte. It
should be stressed, however, that these are images of dif-
ferent cells and that confirmation of this progression
awaits analysis of the development of single cells. The dis-
tribution, morphology, and molecular phenotype of pre-
myelinating oligodendrocytes provide new insights into
mechanisms that regulate their maturation into myelin-
forming cells. Premyelinating oligodendrocytes radiate
Figure 6. Comparison of DM-20/PLP immunoreactivity and nuclear chromatin staining in developing rat brain. Premyelinating oligo-
dendrocytes with DM-20/PLP immunoreactivity evenly distributed on their surface (A) have diffuse nuclear chromatin staining (A, in-
set). Premyelinating oligodendrocytes with fragmented DM-20/PLP staining (B) and DM-20/PLP–positive necrotic-appearing cells (C)
have condensed and fragmented nuclear chromatin (B and C, inset). A, B, and C were photographed with bright field optics; insets were
photographed with ultraviolet optics. Bar, 10 mm.
Table I. Percentage of Dying Premyelinating Oligodendrocytes 
in Developing Cerebral Cortex
Postnatal age Total cells counted
Dying cells
(percentage of total)
7 172 37 (22.0)
11 453 96 (21.4)
14 344 59 (17.9)
21 150 29 (19.6)
28 102 38 (37.8)
DM-20/PLP–positive cells were identified and grouped into cells with continuous
(healthy) or fragmented (dying) immunoreactivity. Sampling was restricted to the
leading edge of myelin in cerebral cortex. Areas of diencephalon were not sampled.
Statistical analysis showed no difference in percentage of dying cells at various time
points.The Journal of Cell Biology, Volume 137, 1997 466
processes in a symmetrical manner and establish spatial
domains within the neuropil. In the cerebral cortex, pro-
cesses of neighboring premyelinating cells do not overlap
even when they appear in pairs. In the corpus callosum,
premyelinating oligodendrocytes usually occur in groups
of two to four cells, their processes overlap extensively,
and each cell occupies z50% of the neuropil domain that
cells in the cortex occupy. Since the number of myelin-
receptive axons is much greater in the corpus callosum
than in the cerebral cortex, these observations support the
hypothesis that axons regulate premyelinating oligoden-
drocyte numbers and morphology (Barres et al., 1992,
1993; Burne et al., 1996; Hardy and Friedrich, 1996). The
spatial separation of premyelinating oligodendrocytes in
the cortex suggests that neighboring cells compete less for
survival factors than the clusters of premyelinating oli-
godendrocytes in the corpus callosum. In addition, the
symmetrical extension of premyelinating oligodendrocyte
processes is consistent with the hypothesis that physical
contact with appropriate axons and/or soluble axon-derived
Figure 7. Premyelinating oligodendrocytes are generated from NG2-positive progenitor cells. Confocal images of sections (30-mm-
thick) from 7-d-old rat cerebral cortices that were immunostained with NG2 (green) and DM-20/PLP (red) antibodies. A network of
NG2-positive cells covers the cortical neuropil (A, green). DM-20/PLP–positive premyelinating cells are less abundant (A, red). A small
but consistent population of cells are weakly stained by both NG2 and DM-20/PLP antibodies (B and C, arrowheads). NG2 immunore-
activity is punctate on the plasma membrane of these cells, whereas DM-20/PLP appears punctate in perinuclear cytoplasm on proximal
cell processes (B and C). Bars, 10 mm.
Figure 8. Schematic sum-
mary of oligodendrocyte lin-
eage in vivo. Progenitor cells
produce premyelinating oli-
godendrocytes. Premyelinat-
ing oligodendrocytes occupy
distinct neuropil domains
and depend on axonal sig-
nal(s) for survival. Images are
two-dimensional  reconstruc-
tions of confocal images.Trapp et al. Oligodendrocyte Lineage In Vitro 467
factors that work over short distances regulate oligoden-
drocyte maturation and survival. The hypothesis that ax-
onal contact is needed for oligodendrocyte survival is also
supported by studies that demonstrated that neurons, but
not neuronal-conditioned medium, can increase the sur-
vival of oligodendrocytes maintained in vitro (Barres and
Raff, 1994).
Differentiation of oligodendrocytes parallels many as-
pects of polarized epithelial cell differentiation. These in-
clude dependence on cell–cell contact, expression of spe-
cific gene products, polarization of cytoskeletal networks,
development of specialized transport pathways, and for-
mation of distinct surface membrane domains (Mostov et al.,
1992; Rodriguez-Boulan and Powell, 1992). Although my-
elinating oligodendrocytes do not form the classical apical
and basolateral membrane domains or tight junctions seen
in typical epithelial cells, they do polarize their surface mem-
branes into several biochemically and morphologically dis-
tinct domains (e.g., compact myelin, paranodal membrane,
periaxonal membranes, perikaryal surface membrane).
Premyelinating oligodendrocytes can be considered as non-
polarized epithelial cells that extend processes in search of
appropriate targets. While our studies support the hypoth-
esis that ensheathment of appropriate axons is required
for the transformation of the nonpolarized premyelinating
oligodendrocyte into a polarized myelinating oligodendro-
cyte, it remains to be determined if axonal contact is the
actual signal.
Our studies indicate that PLP expression and induction
of specialized transport pathways occur as oligodendro-
cytes polarize their surface membranes and form myelin.
The immunocytochemical studies in this report indicate
that DM-20, but not PLP, is expressed by premyelinating
oligodendrocytes. This conclusion is based on the observa-
tion that antibodies directed against epitopes shared by
DM-20 and PLP stain premyelinating oligodendrocytes,
whereas antibodies specific for PLP do not. Although this
could represent different binding affinities for the two an-
tibodies, the PLP antibody demonstrates the same inten-
sity and pattern of staining at 1:6,000 and 1:250 dilutions.
In addition, DM-20 has been identified as a member of an
evolutionarily conserved family of proteins that is ex-
pressed by some neurons, fish myelin, choroid plexus, and
kidney tubules (Kitagawa et al., 1993; Yan et al., 1993;
Yoshida and Colman, 1996). In contrast, PLP evolved as a
myelin-specific protein in amphibians and has not been
identified in other tissues (Yoshida and Colman, 1996).
Our studies raise the possibility that the 35 amino acids
specific to PLP contain signals that target PLP exclusively
to compact myelin or that prevent PLP from being tar-
geted to nonmyelin domains.
Myelin-associated glycoprotein (MAG) and MBP anti-
bodies also stain premyelinating oligodendrocyte cell bod-
ies and processes (Trapp, B.D., unpublished observation).
As premyelinating oligodendrocytes differentiate into my-
elinating oligodendrocytes, they selectively target MAG to
the periaxonal membrane (Trapp et al., 1989), MBP to com-
pact myelin (Sternberger et al., 1978), and MBP mRNA
along the myelin internode (Colman et al., 1982; Trapp et
al., 1987). Myelinating oligodendrocytes, therefore, de-
velop specialized transport pathways that are not present in
premyelinating oligodendrocytes. As described in myeli-
nating Schwann cells (Kidd et al., 1996), axons may induce
specialized microtubule networks in myelinating oligoden-
drocytes that target myelin-specific gene products to dis-
tinct regions of the myelin internode. Alternatively spliced
forms of the MAG and MBP gene are also produced, and
select forms (L-MAG and exon 2–containing MBPs) pre-
dominate during the earliest stages of CNS development
(Quarles et al., 1973; Barbarese et al., 1978). Differential
expression of myelin protein isoforms may be regulated
during oligodendrocyte differentiation by alternative splic-
ing, mRNA stabilization, or translational control.
Death of Premyelinating Oligodendrocytes
Programmed cell death is essential to the development of
many organ systems and assures appropriate cell numbers
and/or appropriate cell–cell contact (Raff et al., 1993).
Previous studies that correlated in vivo and in vitro analy-
ses of oligodendrocyte lineage cells estimated that as many
as 50% of newly generated oligodendrocytes in the optic
nerve undergo programmed cell death (Barres et al., 1992).
Our results established that z20% of premyelinating oli-
godendrocytes in sections of the developing cerebral cor-
tex (7–21 d) are degenerating. If oligodendrocyte survival
depends upon the availability of myelin-receptive axons,
the rate of premyelinating oligodendrocyte death may dif-
fer in white matter tracts and cerebral cortex. The inci-
dence of premyelinating oligodendrocyte death in the ce-
rebral cortex or optic nerve cannot be established until the
life span of premyelinating oligodendrocytes and the clear-
ance time for degenerating oligodendrocytes are deter-
mined.
We did not detect degenerating oligodendrocyte progeni-
tors (NG21 cells) nor significant numbers of degenerating
myelin internodes (PLP-positive). However, hemopoietic
and microglia cells with condensed nuclear chromatin
were detected in both white and gray matter (Trapp, B.D.,
unpublished observation). Premyelinating oligodendrocytes
were not detected in brain areas after they were myeli-
nated. These observations do not support estimates of a
constant rate of oligodendrocyte production and death in
rodent optic nerve during the first six postnatal weeks
(Barres et al., 1992; Raff et al., 1993) and emphasize the
need for phenotyping dying cells identified by nuclear
chromatin fragmentation.
Conclusions
This report used PLP/DM-20–specific antibodies to de-
scribe several aspects of oligodendrocyte differentiation in
vivo. Characterization of oligodendrocyte lineage cells af-
ter experimental manipulation of the developing CNS
should elucidate the molecular events responsible for pro-
duction, survival, and maturation of myelin-forming cells
and identify potential targets for therapeutic intervention
in demyelinating diseases.
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